U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550374) titled 'Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery' on April 13.
Brief Summary: This clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in patients with Parkinson's Disease who have previously undergone deep brain stimulation or deep brain nucleus lesioning surgery.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Parkinson's Disea...